Jiegeng Decoction Potentiates the Anticancer Efficacy of Paclitaxel in vivo and in vitro

• Asıl Yazarlar: Haifang Chen (Yazar), Guofeng Li (Yazar), Ye Liu (Yazar), Yifan Lang (Yazar), Wuliang Yang (Yazar), Wugang Zhang (Yazar), Xinli Liang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Paclitaxel (PTX) has been the first-line treatment for lung cancer; however, its clinical use is limited due to multidrug resistance (MDR) and adverse effects. Thus, there is an urgent need to explore agents that can enhance the anticancer efficacy of PTX by reducing drug resistance and adverse reac...